Reducing costs of surveillance of patients with non-muscle invasive bladder cancer.
- Conditions
- Non-muscle invasive bladder cancersuperficial bladder cancer1003858810004994
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 435
1) (Previous) primary NMIBC
2) Currently under surveillance for possible recurrent disease
3) Monitored by the urology patient archives in the participating hospitals
1) Patients upgraded at reTUR to MIBC
2) Patients presenting with MIBC
3) Patients below 21 years of age. ;After the initial TUR, a second TUR (reTUR) is recommended for patients with pT1 tumors. This is to establish whether resection was radical and when there is remaining tumor whether the tumor is muscle-invasive. In the latter case these patients will be excluded because they do not belong to the NMIBC category
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>- 15% more recurrences detected in the maximal care arm in patients in the<br /><br>low/intermediate risk group.<br /><br>- Proof that in the optimal care arm (intended to be the future follow-up<br /><br>procedure) is safe regarding detected versus missed recurrences.<br /><br>- Calculation of % of cystoscopies that would be unnecessary in the future.<br /><br>- Cost-effectiveness of this strategy.</p><br>
- Secondary Outcome Measures
Name Time Method <p>- 15% more recurrences detected in patients with a primary high-risk tumor.<br /><br>- Indication that these are of lower stage.<br /><br>- Cost-effectiveness.</p><br>